Año: 2023
Journal Impact Factor (JIF): 10.40
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 26/322 | Q1 | T1 | D1 |
Año: 2023
Journal Citation Indicator (JCI): 2,520
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 19/322 | Q1 | T1 | D1 | 94,26 |
Año:
2023
CiteScore:
20,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 15/230 | Q1 | T1 | D1 |
| Oncology | 21/404 | Q1 | T1 | D1 |
SJR año:
2023
Factor de Impacto:
4,623
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 15/233 | Q1 | T1 | D1 |
| Oncology | 20/397 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Bristol Myers Squibb | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Royal Marsden NHS Foundation Trust (United Kingdom) | |
| 2 | Del Vecchio, Michele | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 3 | Mandalá, Mario | Papa Giovanni XIII Hospital (Italy) |
| 4 | Gogas, Helen | National and Kapodistrian University of Athens (Greece) |
| 5 | Arance Fernandez, Ana M. | Hospital Clinic Barcelona (Spain) |
| 6 | Dalle, Stéphane | CHU de Lyon (France) |
| 7 | Cowey, Charles Lance | Baylor Charles A. Sammons Cancer Center (United States) |
| 8 | Schenker, Michael | Sf. Nectarie Oncology Medical Center (Romania) |
| 9 | Grob, Jean Jacques | Aix Marseille Université (France) |
| 10 | Chiarion-Sileni, Vanna | Istituto Oncologico Veneto IOV - IRCCS (Italy) |
| 11 | Marquez-Rodas, Ivan | Hospital General Universitario Gregorio Marañon (Spain) |
| 12 | Butler, Marcus O. | Princess Margaret Cancer Centre (Canada) |
| 13 | Di Giacomo, Anna Maria | Azienda Ospedaliera Universitaria Senese (Italy) |
| 14 | Middleton, Mark R. | Churchill Hospital (United Kingdom) |
| 15 | Lutzky, Jose | Sylvester Comprehensive Cancer Center (United States) |
| 16 | de la Cruz-Merino, Luis | Hospital Universitario Virgen Macarena (Spain) |
| 17 | Arenberger, Petr | Charles University (Czech Republic) |
| 18 | Atkinson, Victoria | Greenslopes Private Hospital (Australia) |
| 19 | Hill, Andrew G. | Tasman Health Care (Australia) |
| 20 | Fecher, Leslie A. | University of Michigan Rogel Cancer Center (United States) |
| 21 | Millward, Michael | University of Western Australia (Australia) |
| 22 | Nathan, Paul D. | Mount Vernon Hospital (United Kingdom) |
| 23 | Khushalani, Nikhil I. | Moffitt Cancer Center (United States) |
| 24 | Queirolo, Paola | Istituto Europeo di Oncologia (Italy) |
| 25 | Ritchings, Corey | Bristol-Myers Squibb (United States) |
| 26 | Lobo, Maurice | Bristol-Myers Squibb (United States) |
| 27 | Askelson, Margarita | Bristol-Myers Squibb (United States) |
| 28 | Tang, Hao | Bristol-Myers Squibb (United States) |
| 29 | Dolfi, Sonia | Bristol-Myers Squibb (United States) |
| 30 | Ascierto, Paolo A. | Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli (Italy) |
| 31 | Weber, Jeffrey | NYU Langone Health (United States) |
